Patients at high risk of cerebrovascular disease: the REACH study
- PMID: 19342835
- DOI: 10.1159/000200443
Patients at high risk of cerebrovascular disease: the REACH study
Abstract
Cerebrovascular disease is one of the leading causes of morbidity and mortality in developed countries. The identification of at-risk individuals is a high priority so that efficacious preventive measures can be implemented. Subjects with the highest risk of cerebrovascular diseases are those who already have had a stroke or a transient ischemic attack, and those with vascular disease in other territories, either in coronary or peripheral arteries. Other subjects at risk are those with cardiac disease, such as atrial fibrillation, those with hypertension, diabetes and smoking habit, as well as individuals with subclinical vascular disease. Although there is considerable evidence for the efficacy of preventive treatment in this population, the percentage of patients receiving optimum treatment is far from ideal. There is a need to implement strategies in the population directed towards increasing awareness of the need to establish healthy habits and adequate preventive pharmacological treatment that could reduce the incidence of this debilitating disease.
(c) 2009 S. Karger AG, Basel.
Similar articles
-
Low rates of preventive practices in patients with peripheral vascular disease.Can J Cardiol. 1999 Nov;15(11):1259-63. Can J Cardiol. 1999. PMID: 10579741
-
Type 3 phosphodiesterase inhibitors may be protective against cerebrovascular events in patients with claudication.J Stroke Cerebrovasc Dis. 2008 May-Jun;17(3):129-33. doi: 10.1016/j.jstrokecerebrovasdis.2007.12.005. J Stroke Cerebrovasc Dis. 2008. PMID: 18436153 Clinical Trial.
-
Risk factor profile and management of cerebrovascular patients in the REACH Registry.Cerebrovasc Dis. 2008;25(4):366-74. doi: 10.1159/000120687. Epub 2008 Mar 13. Cerebrovasc Dis. 2008. PMID: 18337635
-
Coronary, peripheral and cerebrovascular disease: a complex relationship.J Indian Med Assoc. 2010 May;108(5):292-4, 296. J Indian Med Assoc. 2010. PMID: 21121404 Review. No abstract available.
-
[Cerebrovascular mortality in Portugal: are we overemphasizing hypertension and neglecting atrial fibrillation?].Rev Port Cardiol. 2013 Nov;32(11):905-13. doi: 10.1016/j.repc.2013.04.010. Epub 2013 Nov 15. Rev Port Cardiol. 2013. PMID: 24246719 Portuguese.
Cited by
-
The ARTICO study: identification of patients at high risk of vascular recurrence after a first non-cardioembolic stroke.BMC Neurol. 2015 Mar 11;15:28. doi: 10.1186/s12883-015-0278-4. BMC Neurol. 2015. PMID: 25884666 Free PMC article.
-
Pharmacological effects of Salvia miltiorrhiza (Danshen) on cerebral infarction.Chin Med. 2010 Jun 21;5:22. doi: 10.1186/1749-8546-5-22. Chin Med. 2010. PMID: 20565944 Free PMC article.
-
Cigarette smoke extract upregulates heme oxygenase-1 via PKC/NADPH oxidase/ROS/PDGFR/PI3K/Akt pathway in mouse brain endothelial cells.J Neuroinflammation. 2011 Aug 24;8:104. doi: 10.1186/1742-2094-8-104. J Neuroinflammation. 2011. PMID: 21861928 Free PMC article.
-
Are Underlying Assumptions of Current Animal Models of Human Stroke Correct: from STAIRs to High Hurdles?Transl Stroke Res. 2011 Jun;2(2):138-43. doi: 10.1007/s12975-011-0067-3. Epub 2011 Feb 12. Transl Stroke Res. 2011. PMID: 21654913 Free PMC article.
-
Pharmacological effects of Radix Angelica Sinensis (Danggui) on cerebral infarction.Chin Med. 2011 Aug 25;6:32. doi: 10.1186/1749-8546-6-32. Chin Med. 2011. PMID: 21867503 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources